Author | Ronan J. Kelly, MD, MBA | OncLive

Author | Ronan J. Kelly, MD, MBA

Articles

Dr. Kelly on the Outlook of ALK-Positive NSCLC

May 14, 2019

Video

Ronan J. Kelly, MD, MBA, chief of oncology for the 10 Baylor Scott & White Health's North Texas Cancer Centers and director of oncology on the campus of Baylor Charles A. Sammons Cancer Center at Baylor University Medical Center, discusses the outlook of patients with ALK-positive non–small cell lung cancer (NSCLC).

Dr. Kelly Discusses the Treatment of Patients With ALK+ NSCLC

May 07, 2019

Video

Ronan J. Kelly, MD, MBA, chief of oncology for the ten Baylor Scott and White Health's North Texas Cancer Centers and director of oncology on the campus of Baylor Charles A. Sammons Cancer Center at Baylor University Medical Center, discusses the treatment of patients with ALK-positive non–small cell lung cancer.

Dr. Kelly on the Benefit of Immunotherapy in Stage III NSCLC

May 02, 2019

Video

Ronan J. Kelly, MD, MBA, chief of oncology for the ten Baylor Scott & White Health's North Texas Cancer Centers and director of oncology at the Baylor Charles A. Sammons Cancer Center on the campus of Baylor University Medical Center, discusses the benefit of immunotherapy in patients with stage III non–small cell lung cancer (NSCLC).

x